
- Pharmaceutical Technology, February 2023
- Volume 47
- Issue 2
- Pages: 12
Biologics-Specific qPCR Workflows
Thermo Fisher Scientific’s QualTrak is tailored for biologics development.
Thermo Fisher Scientific’s QualTrak is a comprehensive suite of quantitative polymerase chain reaction (qPCR) tools that includes various Applied Biosystems solutions. The product is tailored for biologics development, including monoclonal antibodies, cell and gene therapies, and vaccines.
Among the solutions in QualTrak are the QuantStudio 6 and 7 Pro-Real Time PCR Systems, as well as the TaqMan and TaqPath master mixes and assays. The TaqPath BactoPure master mix is designed to detect as low as one copy of DNA per microliter from bacterial, viral, fungal, and mammalian sources to ensure contamination-free drug product and accurate titers.
QualTrak comes with readily available compliance documentation to reduce the time needed to comply with internal quality systems and regulatory requirements. To support post-discovery steps, such as manufacturing quality control and biodistribution, all master mixes and assays are manufactured at an ISO 13485-certified, FDA registered facility that uses current good manufacturing practices.
Articles in this issue
almost 3 years ago
Combatting Future Viral Threats with Vaccine Advancesalmost 3 years ago
Convergence in the Global Regulatory Villagealmost 3 years ago
Supplementary Handwashing Techniques to Improve Hand Hygienealmost 3 years ago
The Punctuated Evolution of Computer Software Validationalmost 3 years ago
Advantageous Positioning for Europe in Pharmaceutical Cannabisalmost 3 years ago
Harmonizing Rules Governing SPCs for Medicinal Productsalmost 3 years ago
Improving Gender Diversityalmost 3 years ago
FDA Interactions with Industry Under ScrutinyNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




